1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Molecular Diagnosis 1.2.3 Rapid Antigen Testing 1.2.4 Other 1.3 Market by Application 1.3.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Laborary 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Perspective (2016-2027) 2.2 Respiratory Syncytial Virus (RSV) Diagnostics Growth Trends by Regions 2.2.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Respiratory Syncytial Virus (RSV) Diagnostics Historic Market Share by Regions (2016-2021) 2.2.3 Respiratory Syncytial Virus (RSV) Diagnostics Forecasted Market Size by Regions (2022-2027) 2.3 Respiratory Syncytial Virus (RSV) Diagnostics Industry Dynamic 2.3.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Trends 2.3.2 Respiratory Syncytial Virus (RSV) Diagnostics Market Drivers 2.3.3 Respiratory Syncytial Virus (RSV) Diagnostics Market Challenges 2.3.4 Respiratory Syncytial Virus (RSV) Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Respiratory Syncytial Virus (RSV) Diagnostics Players by Revenue 3.1.1 Global Top Respiratory Syncytial Virus (RSV) Diagnostics Players by Revenue (2016-2021) 3.1.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Players (2016-2021) 3.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Respiratory Syncytial Virus (RSV) Diagnostics Revenue 3.4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Concentration Ratio 3.4.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus (RSV) Diagnostics Revenue in 2020 3.5 Respiratory Syncytial Virus (RSV) Diagnostics Key Players Head office and Area Served 3.6 Key Players Respiratory Syncytial Virus (RSV) Diagnostics Product Solution and Service 3.7 Date of Enter into Respiratory Syncytial Virus (RSV) Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Respiratory Syncytial Virus (RSV) Diagnostics Breakdown Data by Type 4.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Historic Market Size by Type (2016-2021) 4.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Forecasted Market Size by Type (2022-2027) 5 Respiratory Syncytial Virus (RSV) Diagnostics Breakdown Data by Application 5.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Historic Market Size by Application (2016-2021) 5.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size (2016-2027) 6.2 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type 6.2.1 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) 6.2.2 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) 6.2.3 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2027) 6.3 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application 6.3.1 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) 6.3.2 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) 6.3.3 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2027) 6.4 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country 6.4.1 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) 6.4.2 North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size (2016-2027) 7.2 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type 7.2.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) 7.2.2 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) 7.2.3 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2027) 7.3 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application 7.3.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) 7.3.2 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) 7.3.3 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2027) 7.4 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country 7.4.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) 7.4.2 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size (2016-2027) 8.2 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type 8.2.1 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2027) 8.3 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application 8.3.1 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2027) 8.4 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region 8.4.1 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size (2016-2027) 9.2 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type 9.2.1 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) 9.2.2 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) 9.2.3 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2027) 9.3 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application 9.3.1 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) 9.3.2 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) 9.3.3 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2027) 9.4 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country 9.4.1 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) 9.4.2 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size (2016-2027) 10.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type 10.2.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2027) 10.3 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application 10.3.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2027) 10.4 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country 10.4.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.1.4 Roche Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.1.5 Roche Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.2.4 AstraZeneca Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.2.5 AstraZeneca Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.3.4 Merck Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.3.5 Merck Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Details 11.4.2 AbbVie Business Overview 11.4.3 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.4.4 AbbVie Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.4.5 AbbVie Recent Development 11.5 Bausch Health 11.5.1 Bausch Health Company Details 11.5.2 Bausch Health Business Overview 11.5.3 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.5.4 Bausch Health Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.5.5 Bausch Health Recent Development 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Company Details 11.6.2 GlaxoSmithKline Business Overview 11.6.3 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.6.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.6.5 GlaxoSmithKline Recent Development 11.7 ReViral 11.7.1 ReViral Company Details 11.7.2 ReViral Business Overview 11.7.3 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.7.4 ReViral Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.7.5 ReViral Recent Development 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Details 11.8.2 Gilead Sciences Business Overview 11.8.3 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.8.4 Gilead Sciences Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.8.5 Gilead Sciences Recent Development 11.9 Teva Pharmaceutical 11.9.1 Teva Pharmaceutical Company Details 11.9.2 Teva Pharmaceutical Business Overview 11.9.3 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Introduction 11.9.4 Teva Pharmaceutical Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) 11.9.5 Teva Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Molecular Diagnosis Table 3. Key Players of Rapid Antigen Testing Table 4. Key Players of Other Table 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Regions (2016-2021) Table 9. Global Respiratory Syncytial Virus (RSV) Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Regions (2022-2027) Table 11. Respiratory Syncytial Virus (RSV) Diagnostics Market Trends Table 12. Respiratory Syncytial Virus (RSV) Diagnostics Market Drivers Table 13. Respiratory Syncytial Virus (RSV) Diagnostics Market Challenges Table 14. Respiratory Syncytial Virus (RSV) Diagnostics Market Restraints Table 15. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Players (2016-2021) Table 17. Global Top Respiratory Syncytial Virus (RSV) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus (RSV) Diagnostics as of 2020) Table 18. Ranking of Global Top Respiratory Syncytial Virus (RSV) Diagnostics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Respiratory Syncytial Virus (RSV) Diagnostics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Respiratory Syncytial Virus (RSV) Diagnostics Product Solution and Service Table 22. Date of Enter into Respiratory Syncytial Virus (RSV) Diagnostics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Type (2016-2021) Table 26. Global Respiratory Syncytial Virus (RSV) Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Application (2016-2021) Table 30. Global Respiratory Syncytial Virus (RSV) Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 62. Roche Company Details Table 63. Roche Business Overview Table 64. Roche Respiratory Syncytial Virus (RSV) Diagnostics Product Table 65. Roche Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 66. Roche Recent Development Table 67. AstraZeneca Company Details Table 68. AstraZeneca Business Overview Table 69. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Product Table 70. AstraZeneca Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 71. AstraZeneca Recent Development Table 72. Merck Company Details Table 73. Merck Business Overview Table 74. Merck Respiratory Syncytial Virus (RSV) Diagnostics Product Table 75. Merck Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 76. Merck Recent Development Table 77. AbbVie Company Details Table 78. AbbVie Business Overview Table 79. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Product Table 80. AbbVie Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 81. AbbVie Recent Development Table 82. Bausch Health Company Details Table 83. Bausch Health Business Overview Table 84. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Product Table 85. Bausch Health Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 86. Bausch Health Recent Development Table 87. GlaxoSmithKline Company Details Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Product Table 90. GlaxoSmithKline Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 91. GlaxoSmithKline Recent Development Table 92. ReViral Company Details Table 93. ReViral Business Overview Table 94. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Product Table 95. ReViral Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 96. ReViral Recent Development Table 97. Gilead Sciences Company Details Table 98. Gilead Sciences Business Overview Table 99. Gilead Sciences Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 100. Gilead Sciences Recent Development Table 101. Teva Pharmaceutical Company Details Table 102. Teva Pharmaceutical Business Overview Table 103. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Product Table 104. Teva Pharmaceutical Revenue in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) & (US$ Million) Table 105. Teva Pharmaceutical Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Type: 2020 VS 2027 Figure 2. Molecular Diagnosis Features Figure 3. Rapid Antigen Testing Features Figure 4. Other Features Figure 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Laborary Case Studies Figure 9. Other Case Studies Figure 10. Respiratory Syncytial Virus (RSV) Diagnostics Report Years Considered Figure 11. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Regions: 2020 VS 2027 Figure 14. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Regions (2022-2027) Figure 15. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Players in 2020 Figure 16. Global Top Respiratory Syncytial Virus (RSV) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus (RSV) Diagnostics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus (RSV) Diagnostics Revenue in 2020 Figure 18. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Type (2016-2021) Figure 19. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Type (2022-2027) Figure 20. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Type (2016-2027) Figure 22. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Application (2016-2027) Figure 23. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Country (2016-2027) Figure 24. United States Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Type (2016-2027) Figure 28. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Application (2016-2027) Figure 29. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Country (2016-2027) Figure 30. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Region (2016-2027) Figure 40. China Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Type (2016-2027) Figure 48. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Application (2016-2027) Figure 49. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Country (2016-2027) Figure 50. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Share by Country (2016-2027) Figure 56. Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Respiratory Syncytial Virus (RSV) Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Roche Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 60. AstraZeneca Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 61. Merck Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 62. AbbVie Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 63. Bausch Health Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 64. GlaxoSmithKline Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 65. ReViral Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 66. Gilead Sciences Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 67. Teva Pharmaceutical Revenue Growth Rate in Respiratory Syncytial Virus (RSV) Diagnostics Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Roche AstraZeneca Merck AbbVie Bausch Health GlaxoSmithKline ReViral Gilead Sciences Teva Pharmaceutical